Prostate cancer, BRCA-mutated
|Page editor||Section editor|
|Laura S. Graham, MD
University of Washington
Fred Hutchinson Cancer Research Center
|Ali Raza Khaki, MD|
Palo Alto, CA
Note: this page has regimens which are specific to prostate cancer that is BRCA-mutated. Please see the main prostate cancer page for other regimens.
|back to top|
|Study||Years of enrollment||Evidence|
|(TRITON2)||2017-NR||Phase II (RT)|
Note: this study is the basis of FDA approval; however, no dosing details are provided on CT.gov and there are no published manuscripts to date.
- TRITON2: NCT02952534